Improve the import management mechanism of plant-derived raw materials and promote the development of the industry

At the National People's Congress this year, Lu Qingguo, a representative of the National People's Congress and chairman of Chenguang Bio, prepared 5 suggestions, mainly related to topics such as the development of the health food industry, the improvement of the import management mechanism of plant extracts, and the entry of Chinese medicine and formula particles into centralized procurement.

The health food industry has huge potential

The "Healthy China 2030" Planning Outline issued by the Central Committee of the Communist Party of China and the State Council requires the health industry to form a group of large internationally competitive enterprises to become the pillar industries of the national economy. The "Five-Year Plan and the Construction of Long-term Goals for 2035" also require comprehensive advancement of the construction of a healthy China and speed up the development of the health industry.

In this regard, Lu Qingguo believes that the health food industry is an important part of the health industry. People’s demand for health food has grown rapidly. In recent years, my country’s health food industry has developed rapidly. The total market size in 2019 will be nearly 400 billion yuan, and it will maintain two positions every year. The number of growth. "Compared with developed countries, there is still a big gap. my country's per capita health food consumption is only 1/7 of that of the United States. The health food industry has huge potential for development. In the next few years, it is hoped that it will develop into a trillion-plus industry and become a new national economy growth point."

However, the health food industry is also facing some problems while developing rapidly.

In Lu Qingguo's view, my country's health food industry lacks leading companies. Due to media publicity and insufficient science popularization, the national trust of domestic health food brands is low, and the public favors foreign brands of health food.

"For example, in recent years, some foreign companies have entrusted Chinese manufacturers to produce health food capsules with domestic raw materials and then export them to foreign countries. When they go abroad, they just bottling and affixing their trademarks. This has suddenly become a foreign high-priced health food business. It has severely affected and restricted the domestic market. The healthy development of the health food industry has damaged the image and national interests of the country."

It is also in this context that Lu Qingguo suggested: First, the Ministry of Industry and Information Technology attaches great importance to the development of the health food industry, and lists the health food industry as an industry that is supported by the state. More measures will be given to market promotion and other aspects to support the cultivation and formation of a group of large-scale enterprises with international competitiveness, which will become the pillar industries of the national economy.

Second, support and encourage the media, scientists and government officials at all levels to correctly guide public opinion, actively publicize and report on the raw materials and production advantages of my country's health food industry, promote excellent companies, and the important role of popular science and health food functional ingredients on the health of the people, so that the people are correct, A rational and objective understanding of domestic health food, gradually enhance the status of domestic health food in the minds of the people, create an atmosphere for the healthy development of the health food industry, and better support the healthy development of my country's health food industry.

Policy needs to be improved

"The plant extraction industry has a good development prospect, which is in line with the market requirements of general health and the improvement of human life quality. my country is rich in plant extraction materials resources, with more than 300 varieties of plant extraction materials. However, due to differences in the natural environment and farming patterns, some foreign countries Raw materials are more advantageous in terms of quality and cost. Chinese plant extraction companies have advantages in extraction technology. If they can rationally allocate global resources, they will comprehensively enhance their position in the international market and become more competitive." Lu Qingguo said.

However, he also pointed out that because the plant extraction industry is an emerging industry, some related policies are not perfect, which has caused some plant extraction materials to be imported normally, product companies cannot produce, and market competitiveness is reduced, which severely restricts the development of my country's plant extraction industry. .

"Take turmeric as an example. According to my country’s current import policy, turmeric cannot be imported as a plant-derived raw material. It can only be imported in accordance with Chinese medicinal materials. Imported drugs must be processed for customs clearance. Only companies with a drug production license or a drug business license can be imported. It can be processed. In addition to turmeric, there are also raw materials such as fennel, saffron, nutmeg, etc., which have this problem and are difficult to import normally." Lu Qingguo gave an example.

In this context, in order to realize the allocation of global resources by enterprises, promote the development of the plant extraction industry, and further enhance the competitiveness of my country's plant extraction enterprises in the international market, Lu Qingguo suggested: State Administration of Market Supervision, General Administration of Customs and other relevant departments improve plants The import management policy of extracted raw materials is based on the import of raw materials required by plant extraction and processing enterprises in accordance with the policy of non-Chinese medicinal materials.

At the same time, enterprises are encouraged to import high-quality agricultural resources from abroad, simplify the access procedures for plant extraction materials, enhance the competitive advantage of my country's plant extraction industry, and promote the healthy development of the plant extraction industry.

Accelerate the centralized procurement of Chinese medicine and formula granules

Traditional Chinese medicine has lasted for thousands of years and is a treasure of Chinese culture. In Lu Qingguo's view, the country attaches great importance to the inheritance and development of Chinese medicine, but the current situation of Chinese medicine is not optimistic. There are more than 5,000 Chinese medicine factories, more than 10,000 Chinese medicine batch numbers, and annual drug revenue of about 800 billion yuan.

"The production of traditional Chinese medicine is small, scattered, and chaotic. A pharmaceutical factory has dozens of varieties and tens of millions of sales. Vicious competition, low-level repetition, emphasis on marketing, neglect of technology, and neglect of management are common phenomena. This is a waste of social resources and government supervision. Increased workload and difficulty." He emphasized.

Therefore, Lu Qingguo believes that the implementation of centralized procurement bidding for traditional Chinese medicine can effectively promote the large-scale production and operation of traditional Chinese medicine enterprises, reduce the cost of traditional Chinese medicine drugs, and enable Chinese medicine enterprises to achieve healthy development while focusing on management and technological progress, thereby promoting the development of the traditional Chinese medicine industry. healthy growth.

Under such a background, he suggested that conditions should be created to enable Chinese patent medicines to enter the mechanism of centralized procurement of medicines through public bidding as soon as possible, so that more Chinese medicine manufacturers can participate in the competition fairly. In addition, it is necessary to improve the standard system and incorporate Chinese medicine formula granules into the drug centralized bidding procurement system to promote the better development of Chinese medicine formula granules.